Filter By Industry
Filter By Tag


Abingdon Health Press releases

1 - 10 of 11 Press Releases

Oct 09, 2019
Patient participation is a fundamental requirement to the overall success of clinical trials. So, lateral flow based mHealth technology needs to be utilised to overcome clinical trial patient recruitment and retention issues.

Oct 08, 2019
A transformation that goes straight to your business' bottom line

Sep 09, 2019
Pharmaceutical Industry's drive to use precision medicine is definitely a move that patients and clinicians welcome in delivering the best outcomes.

Aug 22, 2019
Are you attending Medica this year? If you are, Abingdon Health would very much like the opportunity to meet with you.

Aug 06, 2019
Abingdon Health is championing the use of cost-effective near-patient testing to aid the therapeutic market share and profitability ambitions of pharmaceutical companies in an industry that is set for increased competition.

May 20, 2019
Abingdon Health is pleased to announce Seralite® – FLC Serum, which can be used to diagnose and manage patients with multiple myeloma, has been granted registration by the Brazilian Health Regulatory Agency (ANVISA)

Mar 29, 2019
Abingdon Health is pleased to announce the appointment of Leigh Thomas to the newly created role of Business Development Director.

Feb 01, 2019
A rapid test to be used as an alternative to DNA agarose gel electrophoresis

Dec 20, 2018
New Smartphone lateral flow reader App developed to meet a variety of individual assay and cost requirements.

Jul 26, 2018
Abingdon Health is pleased to announce the availability of a new 'off the shelf' lateral flow reader, the ADxLR5® Developer.

Page: 1 2 Next
Abingdon Health RSS Feed